People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care.

Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

The following guidance is based on the best available evidence. The full guideline gives details of the methods and the evidence used to develop the guidance. Recommendations are also summarised in the algorithms (in the full guideline).

1.1 Good practice in managing faecal incontinence


Because faecal incontinence is a socially stigmatising condition, healthcare professionals should actively yet sensitively enquire about symptoms in high-risk groups (see box 1).

Box 1 High-risk groups

  • frail older people

  • people with loose stools or diarrhoea from any cause

  • women following childbirth (especially following third- and fourth-degree obstetric injury)

  • people with neurological or spinal disease/injury (for example, spina bifida, stroke, multiple sclerosis, spinal cord injury)

  • people with severe cognitive impairment

  • people with urinary incontinence

  • people with pelvic organ prolapse and/or rectal prolapse

  • people who have had colonic resection or anal surgery

  • people who have undergone pelvic radiotherapy

  • people with perianal soreness, itching or pain

  • people with learning disabilities.


Local clinical teams should work as appropriate with local and national organisations to:

  • raise public awareness of the causes, prevalence and symptoms of faecal incontinence and the resources needed to treat it

  • aid mutual support between people with faecal incontinence

  • decrease the taboo surrounding faecal incontinence

  • encourage people with faecal incontinence to seek appropriate help.


All staff working with people with faecal incontinence should be aware of both the physical and the emotional impact this condition can have on individuals and their carers.


Healthcare professionals should ensure that people with faecal incontinence and their carers:

  • are kept fully informed about their condition and have access to appropriate sources of information in formats and languages suited to their individual requirements

  • are offered access to or made aware of appropriate support groups (which may include alerting people with faecal incontinence to the possibility of family and friends having similar experiences, or suggesting community groups or more formal organisations). Consideration should be given to the individual's cognition, gender, physical needs, culture and stage of life

  • have the opportunity to discuss assessment, management options and relevant physical, emotional, psychological and social issues. The views, experiences, attitudes and opinions of the individual with faecal incontinence about these issues should be actively sought.


When assessing faecal incontinence healthcare professionals should:

  • be aware that faecal incontinence is a symptom, often with multiple contributory factors for an individual

  • avoid making simplistic assumptions that causation is related to a single primary diagnosis ('diagnostic overshadowing').

1.2 Baseline assessment


Healthcare professionals should ensure that people who report or are reported to have faecal incontinence are offered:

  • a focused baseline assessment to identify the contributory factors before any treatment is considered

  • all appropriate initial management including, where appropriate, condition-specific interventions before any specialised treatment.


The focused baseline assessment should comprise:

  • relevant medical history (see table 1)

  • a general examination

  • an anorectal examination (see table 1)

  • a cognitive assessment, if appropriate.


People with the following conditions should have these addressed with condition-specific interventions before healthcare professionals progress to initial management of faecal incontinence:

  • faecal loading (see also section 1.7.3)

  • potentially treatable causes of diarrhoea (for example, infective, inflammatory bowel disease and irritable bowel syndrome)

  • warning signs for lower gastrointestinal cancer. See the NICE guideline on the recognition and referral of suspected cancer.

  • rectal prolapse or third-degree haemorrhoids

  • acute anal sphincter injury including obstetric and other trauma

  • acute disc prolapse/cauda equina syndrome.

1.3 Initial management


Healthcare professionals should explain to people with faecal incontinence that a combination of initial management interventions is likely to be needed. The specific management intervention(s) offered should be based on the findings from the baseline assessment, tailored to individual circumstances and adjusted to personal response and preference.

Diet, bowel habit and toilet access


Healthcare professionals should recommend a diet that promotes an ideal stool consistency and predictable bowel emptying. When addressing food and fluid intake healthcare professionals should:

  • take into account existing therapeutic diets

  • ensure that overall nutrient intake is balanced

  • consider a food and fluid diary to help establish a baseline

  • advise patients to modify 1 food at a time if attempting to identify potentially contributory factors to their symptoms (see tables 2 and 3)

  • encourage people with hard stools and/or clinical dehydration to aim for at least 1.5 litres intake of fluid per day (unless contraindicated). Urinary output should be measured where intake is in doubt

  • consider the opportunity to screen people with faecal incontinence for malnutrition, or risk of malnutrition. See the NICE guideline on nutrition support for adults.


Healthcare professionals should address the individual's bowel habit, aiming for ideal stool consistency and satisfactory bowel emptying at a predictable time.


A bowel habit intervention should contain the following elements:

  • encouraging bowel emptying after a meal (to utilise the gastrocolic response)

  • ensuring toilet facilities are private and comfortable and can be used in safety, with sufficient time allowed

  • encouraging people to adopt a sitting or squatting position where possible while emptying the bowel

  • teaching people techniques to facilitate bowel evacuation and stressing the importance of avoiding straining.


When problems with toilet access are being addressed in any home or healthcare setting:

  • locations of toilets should be made clear to the individual where appropriate

  • equipment to help people to gain access to a toilet should be provided

  • advice should be given to people with faecal incontinence on easily removable clothing to reduce time needed for access

  • if a person with faecal incontinence is dependent on others for access to the toilet, help should be readily available

  • if appropriate, people with faecal incontinence should be referred to the relevant professionals for assessment of their home and/or mobility.



When reviewing medication, healthcare professionals should consider alternatives to drugs that might be contributing to faecal incontinence. (see table 4)


Antidiarrhoeal medication should be offered to people with faecal incontinence associated with loose stools once other causes (such as excessive laxative use, dietary factors and other medication) have been excluded. Antidiarrhoeal medication should be prescribed in accordance with the summary of product characteristics (SPC).


The antidiarrhoeal drug of first choice should be loperamide hydrochloride. It can be used long term in doses from 0.5 mg to 16 mg per day as required. For doses under 2 mg, loperamide hydrochloride syrup should be considered. People who are unable to tolerate loperamide hydrochloride should be offered codeine phosphate or co-phenotrope. Prescribers should check the SPC for current licensed indications. Informed consent is needed when using outside the licensed indications. This should be discussed and documented in the notes. For guidance on safe prescribing of opioids (such as codeine phosphate) and managing withdrawal, see NICE's guideline on medicines associated with dependence or withdrawal symptoms.


Loperamide hydrochloride should not be offered to people with:

  • hard or infrequent stools

  • acute diarrhoea without a diagnosed cause

  • an acute flare-up of ulcerative colitis.


When loperamide hydrochloride is used:

  • it should be introduced at a very low dose and the dose should be escalated, as tolerated by the individual, until the desired stool consistency has been achieved

  • it should be taken as and when required by the individual

  • individuals should be advised that they can adjust the dose and/or frequency up or down in response to stool consistency and their lifestyle.

Coping strategies


During assessment and initial management healthcare professionals should offer people with faecal incontinence advice on coping strategies including:

  • the use of continence products and information about product choice, supply sources and use

  • where to get emotional and psychological support, including counselling or psychological therapy, where appropriate, to foster acceptance and positive attitudes

  • how to talk to friends and family about incontinence and its management

  • strategies such as planning routes for travel to facilitate access to public conveniences, carrying a toilet access card or RADAR key to allow access to 'disabled' toilets in the National Key Scheme.


People with faecal incontinence should be offered:

  • disposable body-worn pads in a choice of styles and designs and disposable bed pads if needed

  • pads in quantities sufficient for the individual's continence needs – it is inappropriate to limit the number of pads given

  • anal plugs (for people who can tolerate them)

  • skin-care advice that covers both cleansing and barrier products

  • advice on odour control and laundry needs

  • disposable gloves.


The use of reusable absorbent products in the management of faecal incontinence is not generally recommended.

Review of treatment


After each intervention healthcare professionals should ask the person whether the faecal incontinence has improved. People continuing to experience symptoms should be:

  • involved in discussions about further treatment options (including effectiveness and adverse effects) or alternative coping strategies

  • asked if they wish to try further treatments.


The options for long-term management should be considered for people who prefer symptomatic management to more invasive measures (see recommendation in section 1.6).

1.4 Specialised management


People who continue to have episodes of faecal incontinence after initial management should be considered for specialised management. This may involve referral to a specialist continence service, which may include:

  • pelvic floor muscle training

  • bowel retraining

  • specialist dietary assessment and management

  • biofeedback

  • electrical stimulation

  • rectal irrigation.

    Some of these treatments might not be appropriate for people who are unable to understand and/or comply with instructions. For example, pelvic floor re-education programmes might not be appropriate for those with neurological or spinal disease/injury resulting in faecal incontinence.


Healthcare professionals should consider in particular whether people with neurological or spinal disease/injury resulting in faecal incontinence, who have some residual motor function and are still symptomatic after baseline assessment and initial management, could benefit from specialised management (see also section 1.7).


Any programme of pelvic floor muscle training should be agreed with the person. A patient-specific exercise regimen should be provided based on the findings of digital assessment. The progress of people having pelvic floor muscle training should be monitored by digital reassessment carried out by an appropriately trained healthcare professional who is supervising the treatment. There should be a review of the person's symptoms on completion of the programme and other treatment options considered if appropriate.

1.5 Specialist assessment


People with continuing faecal incontinence after specialised conservative management should be considered for specialist assessment, including:

  • anorectal physiology studies

  • endoanal ultrasound; if this is not available, magnetic resonance imaging, endovaginal ultrasound and perineal ultrasound should be considered

  • other tests, including proctography, as indicated.

1.6 Long-term management


Healthcare professionals should offer the following to symptomatic people who do not wish to continue with active treatment or who have intractable faecal incontinence:

  • advice relating to the preservation of dignity and, where possible, independence

  • psychological and emotional support, possibly including referral to counsellors or therapists if it seems likely that a person's attitude towards and ability to manage and cope with his or her faecal incontinence could improve with professional assistance

  • at least 6‑monthly review of symptoms

  • discussion of any other management options (including specialist referral)

  • contact details for relevant support groups

  • advice on continence products and information about product choice, availability and use

  • advice on skin care

  • advice on how to talk to friends and family

  • strategies such as planning routes for travel to facilitate access to public conveniences, carrying a toilet access card or RADAR key.

1.7 Management of specific groups


Healthcare professionals should take a proactive approach to bowel management for specific groups of people (see box 2).

Box 2 Specific groups

  • people with faecal loading or constipation

  • people with limited mobility

  • hospitalised patients who are acutely unwell and who develop acute faecal loading and associated incontinence.

  • people with cognitive or behavioural issues

  • people with neurological or spinal disease/injury resulting in faecal incontinence

  • people with learning disabilities

  • severely or terminally ill people

  • people with acquired brain injury.

People with faecal loading


People in whom acute severe faecal loading is identified as contributing to faecal incontinence should initially be offered a rectally administered treatment to satisfactorily clear the bowel. Often treatment will need to be repeated daily for a few days, depending on tolerance and whether satisfactory bowel clearance is achieved.


If rectal interventions are not appropriate or fail to satisfactorily clear the bowel, and bowel obstruction has been excluded as a possible cause, a potent oral laxative should be offered. People should be informed that oral laxatives may cause griping abdominal pain, loose stools and prolonged bowel activity. Toilet access should be ensured.


Healthcare professionals involved in the management of faecal incontinence associated with chronic ongoing faecal loading/impaction should aim to reduce the chance of recurrence by recommending a combination of initial management options tailored to the individual (see recommendation 1.3.1). If this fails, the use of orally administered laxatives to promote bowel emptying should be considered. Rectally administered preparations should be used if oral laxatives cause episodes of faecal incontinence and there is a need to produce planned bowel evacuations.

People with limited mobility


People with limited mobility who continue to have episodes of faecal incontinence after initial management should be offered a regimen that will produce a planned, predicted bowel action when carers are present if needed. This may be achieved by a combination of oral or rectal laxatives and/or constipating agents. This regimen should also consider:

People using enteral tube feeding and reporting faecal incontinence


Healthcare professionals should ensure that people with faecal incontinence who are receiving enteral tube feeding have their type and timing of feed modified on an individual basis to establish the most effective way to manage faecal incontinence.

People with severe cognitive impairment


If baseline assessment and initial management have failed to resolve faecal incontinence, people with confirmed severe cognitive impairment should be referred for a behavioural and functional analysis to determine if there is any behavioural reason for faecal incontinence. Following analysis, people should be offered cause-specific interventions founded on structured goal planning that aim to resolve as well as manage behavioural aspects that may be contributing to faecal incontinence. In cases of severe cognitive impairment, further specialist management of faecal incontinence may be inappropriate.

People with neurological or spinal disease/injury


People with neurological or spinal disease/injury resulting in faecal incontinence who continue to have episodes of faecal incontinence after initial management should be offered a neurological bowel management programme. This aims to achieve a predictable routine and avoid faecal incontinence and severe constipation. Management should involve progressing through the following steps until satisfactory bowel habit is established:

  • ascertaining individual preferences

  • ascertaining premorbid bowel habit, if possible

  • maximising the individual's understanding of normal bowel function and how it has been altered

  • modifying diet and/or administrating rectal evacuants and/or oral laxatives, adjusted to individual response, to attempt to establish a predictable pattern of bowel evacuation

  • consideration of digital anorectal stimulation for people with spinal cord injuries or other neurogenic bowel disorders

  • consideration of manual/digital removal of faeces, particularly for people with a lower spinal injury, if there is a hard plug of faeces in the rectum, presence of faecal impaction, incomplete defaecation, an inability to defaecate and/or all other bowel-emptying techniques have failed to achieve bowel emptying and continence within a time acceptable to the individual.


Healthcare professionals should discuss the following management options with people unable to achieve reliable bowel continence after a neurological bowel management programme:

  • coping and long-term management strategies for symptomatic individuals (see recommendations in section 1.3.11 and section 1.6)

  • rectal irrigation if appropriate

  • other surgical options (including stoma) if faecal incontinence or the time taken for bowel emptying imposes major limits on their lifestyle.

People with learning disabilities


People with severe learning disabilities may have had faecal incontinence from childhood. Others may experience faecal incontinence for the first time in adulthood. It is essential that these individuals follow the same initial care pathway as other people with faecal incontinence. They may require additional support during assessment and management to achieve equal outcomes.

Severely or terminally ill people


Healthcare professionals should consider a faecal collection device for people in intensive care settings and people receiving palliative care with faecal incontinence and associated loose stools.

1.8 Surgery


All people with faecal incontinence considering or being considered for surgery should be referred to a specialist surgeon to discuss:

  • the surgical and non-surgical options appropriate for their individual circumstances

  • the potential benefits and limitations of each option, with particular attention to long-term results

  • realistic expectations of the effectiveness of any surgical procedures under consideration.


People with a full-length external anal sphincter defect that is 90 degrees or greater (with or without an associated internal anal sphincter defect) and faecal incontinence that restricts quality of life should be considered for sphincter repair. They should be given a realistic expectation of what this operation can achieve and information about possible adverse events, in both the short and long terms.


People with internal sphincter defects, pudendal nerve neuropathy, multiple defects, external sphincter atrophy, loose stools or irritable bowel syndrome should be informed that these factors are likely to decrease the effectiveness of anal sphincter repair.


People undergoing anal sphincter repair should not routinely receive a temporary defunctioning stoma.


People undergoing anal sphincter repair should not receive constipating agents in the postoperative period and should be allowed to eat and drink as soon as they feel able to.


A trial of temporary sacral nerve stimulation should be considered for people with faecal incontinence in whom sphincter surgery is deemed inappropriate. See the NICE interventional procedures guidance on sacral nerve stimulation for faecal incontinence. These may be patients with intact anal sphincters, or those with sphincter disruption. In those with a defect, contraindications to direct repair may include atrophy, denervation, a small defect, absence of voluntary contraction, fragmentation of the sphincter or a poor-quality muscle.


All individuals should be informed of the potential benefits and limitations of this procedure and should undergo a trial stimulation period of at least 2 weeks to determine if they are likely to benefit. People with faecal incontinence should be offered sacral nerve stimulation on the basis of their response to percutaneous nerve evaluation during specialist assessment, which is predictive of therapy success. People being considered for sacral nerve stimulation should be assessed and managed at a specialist centre that has experience of performing this procedure.


If a trial of sacral nerve stimulation is unsuccessful, an individual can be considered for a neosphincter, for which the 2 options are a stimulated graciloplasty or an artificial anal sphincter. See also the NICE interventional procedures guidance on stimulated graciloplasty for faecal incontinence. People should be informed of the potential benefits and limitations of both procedures. Those offered these procedures should be informed that they may experience evacuatory disorders and/or serious infection, either of which may necessitate removal of the device. People being considered for either procedure should be assessed and managed at a specialist centre with experience of performing these procedures. If an artificial anal sphincter is to be used, there are special arrangements that should be followed, as indicated in the NICE interventional procedures guidance on artificial anal sphincter implantation.


People who have an implanted sacral nerve stimulation device, stimulated graciloplasty or an artificial anal sphincter should be offered training and ongoing support at a specialist centre. These people should be monitored, have regular reviews and be given a point of contact.


Antegrade irrigation via appendicostomy, neo-appendicostomy or continent colonic conduit may be considered in selected people with constipation and colonic motility disorders associated with faecal incontinence.


A stoma should be considered for people with faecal incontinence that severely restricts lifestyle only once all appropriate non-surgical and surgical options, including those at specialist centres, have been considered. Individuals should be informed of the potential benefits, risks and long-term effects of this procedure. Individuals assessed as possible candidates for a stoma should be referred to a stoma care service.